Robert L. Ferris, MD, PhD | Authors


After More Than 30 Years, Research on HER2 Continues to Expand Our Understanding of Cancer

July 03, 2021

It has taken some decades, but the identification of targets such as HER2 has enabled us to segregate cancers into different subtypes, develop novel therapeutic strategies, and eventually understand the biology distinguishing one group of patients from another, says Robert L. Ferris, MD, PhD.